Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (1-10 of 349) with videos related to

Pageof 35
Sort By:
Translational and Clinical Pharmacology|April 15, 2021
A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsyJuYeun Jeon, Jaeseong Oh, Kyung-Sang Yu
Journal of Korean Medical Science|September 14, 2020
The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in KoreaJuYeun Jeon, Hyeikyoung Kim, Kyung Sang Yu
CPT: Pharmacometrics & Systems Pharmacology|March 27, 2023
Prediction of gastric pH-mediated drug exposure using physiologically-based pharmacokinetic modeling: A case study of itraconazoleEunsol Yang, Kyung-Sang Yu, SeungHwan Lee
Translational and Clinical Pharmacology|April 10, 2023
Analysis of the distribution of trial sites in South Korea using social network analysisKi Young Huh, Kyung-Sang Yu, Ildae Song
Clinical and Translational Science|June 6, 2025
Integrating Personal Health Records to Improve Data Integrity in Trials With Decentralized Elements: A Pilot StudyYoonjin Kim, Ki Young Huh, Kyung-Sang Yu
Drug Design, Development and Therapy|June 18, 2020
Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate TabletsJun Gi Hwang, Kyung-Sang Yu, SeungHwan Lee
Drug Design, Development and Therapy|October 17, 2025
Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean SubjectsJaegu Kang, Sungyeun Bae, Kyung-Sang Yu, et al.
Translational and Clinical Pharmacology|April 10, 2025
Comparison of pharmacokinetics of a fixed-dose combination of atorvastatin/ezetimibe 5 mg/10 mg versus separate tablets in healthy subjectsJisoo Song, Sungyeun Bae, Kyung-Sang Yu, et al.
Clinical Therapeutics|May 5, 2020
An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy MenSeol Ju Moon, Kyung-Sang Yu, Min-Gul Kim
Drug Design, Development and Therapy|September 15, 2025
Pharmacokinetic and Safety Profiles of MIT-001, a Novel Ferroptosis Inhibitor, After Subcutaneous Administration in Healthy ParticipantsSujong Lee, Sungyeun Bae, Kyung-Sang Yu, et al.
Pageof 35

Showing results (1-10 of 349) with videos related to

Sort By:
Pageof 35
Translational and Clinical Pharmacology|April 15, 2021
A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsyJuYeun Jeon, Jaeseong Oh, Kyung-Sang Yu
Journal of Korean Medical Science|September 14, 2020
The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in KoreaJuYeun Jeon, Hyeikyoung Kim, Kyung Sang Yu
CPT: Pharmacometrics & Systems Pharmacology|March 27, 2023
Prediction of gastric pH-mediated drug exposure using physiologically-based pharmacokinetic modeling: A case study of itraconazoleEunsol Yang, Kyung-Sang Yu, SeungHwan Lee
Translational and Clinical Pharmacology|April 10, 2023
Analysis of the distribution of trial sites in South Korea using social network analysisKi Young Huh, Kyung-Sang Yu, Ildae Song
Clinical and Translational Science|June 6, 2025
Integrating Personal Health Records to Improve Data Integrity in Trials With Decentralized Elements: A Pilot StudyYoonjin Kim, Ki Young Huh, Kyung-Sang Yu
Drug Design, Development and Therapy|June 18, 2020
Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate TabletsJun Gi Hwang, Kyung-Sang Yu, SeungHwan Lee
Drug Design, Development and Therapy|October 17, 2025
Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean SubjectsJaegu Kang, Sungyeun Bae, Kyung-Sang Yu, et al.
Translational and Clinical Pharmacology|April 10, 2025
Comparison of pharmacokinetics of a fixed-dose combination of atorvastatin/ezetimibe 5 mg/10 mg versus separate tablets in healthy subjectsJisoo Song, Sungyeun Bae, Kyung-Sang Yu, et al.
Clinical Therapeutics|May 5, 2020
An Assessment of Pharmacokinetic Interaction Between Lobeglitazone and Sitagliptin After Multiple Oral Administrations in Healthy MenSeol Ju Moon, Kyung-Sang Yu, Min-Gul Kim
Drug Design, Development and Therapy|September 15, 2025
Pharmacokinetic and Safety Profiles of MIT-001, a Novel Ferroptosis Inhibitor, After Subcutaneous Administration in Healthy ParticipantsSujong Lee, Sungyeun Bae, Kyung-Sang Yu, et al.
Pageof 35